These clinicopathological features suggest the possibility of <i>ETV6-NTRK3</i> rearranged thyroid carcinoma and highlight the importance of performing gene fusion testing by FISH or NGS for these patients. The gene discussed is NTRK3; the disease is thyroid gland carcinoma.